🇺🇸 FDA
Pipeline program

ET-01

EDI-001-002

Unknown mab terminated

Quick answer

ET-01 for Transfusion Dependent Beta-Thalassaemia is a Unknown program (mab) at Guangzhou Virotech Pharmaceutical Co., with 1 ClinicalTrials.gov record(s).

Program details

Company
Guangzhou Virotech Pharmaceutical Co.,
Indication
Transfusion Dependent Beta-Thalassaemia
Phase
Unknown
Modality
mab
Status
terminated

Clinical trials